ENCY2 CONSULTING

Small molecule medicinal chemistry and structure-based drug design consultants with expertise in multiple disease areas and particular expertise in antibacterial, anticancer, central nervous system disorders and cardiovascular disease. Former research directors from major pharmaceutical (Merck, Aventis, Johnson & Johnson) and biotech (Myogen, Replidyne, & Gilead) companies... Rational molecule selection for lead identification, scaffold hopping, or lead optimization. Lead optimization and ligand design using classical medicinal chemistry and structure-based design techniques, including fragment-based approaches. Intellectual property analysis and assistance with patent submission. Strategic advice and input with grant solicitations.

Also known as: Ency2 Consulting, LLC